Direkt zum Inhalt
Merck
  • Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium.

Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium.

British journal of pharmacology (2014-04-05)
Inês Carneiro, M Alexandrina Timóteo, Isabel Silva, Cátia Vieira, Catarina Baldaia, Fátima Ferreirinha, Miguel Silva-Ramos, Paulo Correia-de-Sá
ZUSAMMENFASSUNG

Despite the abundant expression of the UDP-sensitive P2Y6 receptor in urothelial cells and sub-urothelial myofibroblasts its role in the control of bladder function is not well understood. We compared the effects of UDP and of the selective P2Y6 receptor agonist, PSB0474, on bladder urodynamics in anaesthetized rats; the voided fluid was tested for ATP bioluminescence. The isolated urinary bladder was used for in vitro myographic recordings and [(3) H]-ACh overflow experiments. Instillation of UDP or PSB0474 into the bladder increased the voiding frequency (VF) without affecting the amplitude (A) and the duration (Δt) of bladder contractions; an effect blocked by the P2Y6 receptor antagonist, MRS2578. Effects mediated by urothelial P2Y6 receptors required extrinsic neuronal circuitry as they were not detected in the isolated bladder. UDP-induced bladder hyperactvity was also prevented by blocking P2X3 and P2Y1 receptors, respectively, with A317491 and MRS2179 applied i.v.. UDP decreased [(3) H]-ACh release from stimulated bladder strips with urothelium, but not in its absence. Inhibitory effects of UDP were converted into facilitation by the P2Y1 receptor antagonist, MRS2179. The P2Y6 receptor agonist increased threefold ATP levels in the voided fluid. Activation of P2Y6 receptors increased the voiding frequency indirectly by releasing ATP from the urothelium and activation of P2X3 receptors on sub-urothelial nerve afferents. Bladder hyperactivity may be partly reversed following ATP hydrolysis to ADP by E-NTPDases, thereby decreasing ACh release from cholinergic nerves expressing P2Y1 receptors.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumperiodat, ACS reagent, ≥99.8%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Cholinchlorid, ≥98%
Sigma-Aldrich
Natrium-(Meta-)Periodat, ≥99.0%
Sigma-Aldrich
Cholinchlorid, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
Sigma-Aldrich
Thioharnstoff, ACS reagent, ≥99.0%
Sigma-Aldrich
Cholinchlorid, ≥99%
Sigma-Aldrich
Urethan, ≥99%
Sigma-Aldrich
Thioharnstoff, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Cholinchlorid, BioUltra, ≥99.0% (AT)
Sigma-Aldrich
Urethan, ≥99.0% (GC)
Supelco
Cholinchlorid, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Cholinchlorid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Natrium-(Meta-)Periodat, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
Pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid) tetrasodium salt hydrate, solid, ≥98% (HPLC)
Supelco
Urethan, analytical standard
Sigma-Aldrich
N6-Methyl-2′-deoxyadenosine